The One Stock You Must Watch
An industry-shattering disruption is coming - this microcap is at the heart of it.
Click for ticker & full details

HRTX Insider Trading (Heron Therapeutics)

Insider Ownership Percentage: 4.63%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $18,331.04

Heron Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Heron Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Heron Therapeutics Share Price & Price History

Current Price: $3.61
Price Change: Price Increase of +0.02 (0.56%)
As of 05/16/2022 04:02 PM ET

This chart shows the closing price history over time for HRTX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Warning: The Last Value Play Gone After August?
In this market...There's ONE STOCK (priced at just under $2) that could be $20 and STILL be a bargain. It brought in more income – including equity sales - in the last 12 months than Disney, Square or Tesla.

But a key announcement in August could send this stock rocketing skyward.
Get the Details Now.

Heron Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/3/2022Kimberly ManhardEVPSell1,504$4.76$7,159.0410,872View SEC Filing Icon  
12/21/2021Christian WaageDirectorSell300$9.73$2,919.00View SEC Filing Icon  
9/21/2021Christian WaageDirectorSell300$12.31$3,693.00View SEC Filing Icon  
6/21/2021Christian WaageDirectorSell300$15.20$4,560.003,800View SEC Filing Icon  
5/3/2021Kimberly ManhardEVPSell1,529$17.66$27,002.143,163View SEC Filing Icon  
4/15/2021Christian WaageDirectorSell300$17.51$5,253.004,100View SEC Filing Icon  
4/6/2021Craig A. JohnsonDirectorSell250$17.22$4,305.003,590View SEC Filing Icon  
1/14/2021David Leslie SzekeresCOOSell827$18.09$14,960.431,250View SEC Filing Icon  
1/8/2021David Leslie SzekeresCOOSell3,571$19.66$70,205.86View SEC Filing Icon  
5/1/2020Kimberly ManhardVPSell1,158$13.97$16,177.261,158View SEC Filing Icon  
11/29/2019Kimberly ManhardVPSell24,000$26.00$624,000.0024,000View SEC Filing Icon  
10/4/2019Kevin C TangDirectorBuy285,714$17.50$4,999,995.00View SEC Filing Icon  
10/3/2019Barry D QuartCEOBuy4,571$17.50$79,992.5090,081View SEC Filing Icon  
10/3/2019John PoyhonenEVPBuy5,143$17.50$90,002.5018,143View SEC Filing Icon  
9/30/2019John PoyhonenInsiderBuy11,105$22.62$251,195.10
5/22/2019John PoyhonenDirectorBuy3,000$17.55$52,650.0013,000View SEC Filing Icon  
See Full Table
The American Antidote for Chinese Lithium?
Switching to renewable energy means lithium demand could skyrocket 1,000% by 2030. But China controls 80% of the world's lithium supply, and the U.S. warns that China's monopoly is a national security and economic threat. Nevada's famed lithium deposits could be the best antidote to fight back against Chinese lithium domination.
See Why Nevada Lithium Should be on Your Radar

SEC Filings (Institutional Ownership Changes) for Heron Therapeutics (NASDAQ:HRTX)

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at HRTX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Heron Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/16/2022Woodline Partners LP569,155$3.26M0.1%+2.0%0.555%Search for SEC Filing on Google Icon
5/16/2022Wellington Management Group LLP1,729,772$9.89M0.0%+5.6%1.688%Search for SEC Filing on Google Icon
5/16/2022State Street Corp12,923,369$73.92M0.0%+68.0%12.611%Search for SEC Filing on Google Icon
5/16/2022Orchard Capital Managment LLC966,924$5.53M1.6%+164.2%0.944%Search for SEC Filing on Google Icon
5/16/2022Prelude Capital Management LLC20,600$0.12M0.0%N/A0.020%Search for SEC Filing on Google Icon
5/16/2022Suvretta Capital Management LLC2,869,048$16.41M0.5%+15.4%2.800%Search for SEC Filing on Google Icon
5/16/2022Engineers Gate Manager LP12,838$73K0.0%N/A0.013%Search for SEC Filing on Google Icon
5/16/2022Zullo Investment Group Inc.6,300$36K0.0%+90.9%0.006%Search for SEC Filing on Google Icon
5/16/2022Invesco Ltd.71,933$0.41M0.0%+15.0%0.070%Search for SEC Filing on Google Icon
5/16/2022UBS Group AG234,120$1.34M0.0%-26.7%0.228%Search for SEC Filing on Google Icon
5/16/2022Hsbc Holdings PLC19,698$0.11M0.0%N/A0.019%Search for SEC Filing on Google Icon
5/13/2022Northern Trust Corp915,569$5.24M0.0%-4.8%0.893%Search for SEC Filing on Google Icon
5/13/2022Charles Schwab Investment Management Inc.715,306$4.09M0.0%+2.7%0.698%Search for SEC Filing on Google Icon
5/13/2022XTX Topco Ltd20,436$0.12M0.1%N/A0.020%Search for SEC Filing on Google Icon
5/13/2022American International Group Inc.45,869$0.26M0.0%-6.6%0.045%Search for SEC Filing on Google Icon
5/13/2022Pier 88 Investment Partners LLC136,330$0.78M0.3%+37.9%0.133%Search for SEC Filing on Google Icon
5/13/2022Bridgefront Capital LLC10,493$60K0.1%N/A0.010%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.9,934,688$56.83M0.0%+3.4%9.694%Search for SEC Filing on Google Icon
5/13/2022Pekin Hardy Strauss Inc.598,265$3.42M0.4%+4.9%0.584%Search for SEC Filing on Google Icon
5/13/2022Allianz Asset Management GmbH155,085$0.89M0.0%-28.1%0.151%Search for SEC Filing on Google Icon
5/13/2022Dimensional Fund Advisors LP318,705$1.82M0.0%-5.4%0.311%Search for SEC Filing on Google Icon
5/12/2022Integral Health Asset Management LLC1,000,000$5.72M1.5%+33.3%0.979%Search for SEC Filing on Google Icon
5/12/2022BlackRock Inc.8,156,131$46.65M0.0%+6.2%7.985%Search for SEC Filing on Google Icon
5/12/2022Panagora Asset Management Inc.13,547$77K0.0%-85.2%0.013%Search for SEC Filing on Google Icon
5/12/2022Metropolitan Life Insurance Co NY6,126$35K0.0%-77.2%0.006%Search for SEC Filing on Google Icon
5/12/2022Jacob Asset Management of New York LLC137,255$0.79M0.5%+127.4%0.134%Search for SEC Filing on Google Icon
5/12/2022MetLife Investment Management LLC53,564$0.31M0.0%+63.4%0.052%Search for SEC Filing on Google Icon
5/12/2022D.A. Davidson & CO.222,142$1.27M0.0%+9.2%0.217%Search for SEC Filing on Google Icon
5/12/2022Bank of Montreal Can100,600$0.57M0.0%-38.0%0.098%Search for SEC Filing on Google Icon
5/12/2022E Fund Management Co. Ltd.47,763$0.27M0.0%+160.0%0.047%Search for SEC Filing on Google Icon
5/12/2022Citigroup Inc.150,607$0.86M0.0%-65.8%0.147%Search for SEC Filing on Google Icon
5/12/2022Connor Clark & Lunn Investment Management Ltd.125,932$0.72M0.0%N/A0.123%Search for SEC Filing on Google Icon
5/11/2022Bank of New York Mellon Corp304,733$1.74M0.0%+2.0%0.298%Search for SEC Filing on Google Icon
5/11/2022JPMorgan Chase & Co.6,126,136$35.04M0.0%-2.1%5.998%Search for SEC Filing on Google Icon
5/11/2022GSA Capital Partners LLP148,272$0.85M0.1%+331.3%0.145%Search for SEC Filing on Google Icon
5/10/2022Searle & CO.33,250$0.19M0.1%-30.4%0.033%Search for SEC Filing on Google Icon
5/9/2022CM Management LLC200,000$1.14M1.0%+300.0%0.196%Search for SEC Filing on Google Icon
5/9/2022Swiss National Bank229,000$1.31M0.0%+7.2%0.224%Search for SEC Filing on Google Icon
5/9/2022Palisade Capital Management LLC NJ2,921,107$16.71M0.4%-3.7%2.860%Search for SEC Filing on Google Icon
5/9/2022Qube Research & Technologies Ltd77,081$0.44M0.0%N/A0.075%Search for SEC Filing on Google Icon
5/6/2022Grimes & Company Inc.15,088$86K0.0%+30.9%0.015%Search for SEC Filing on Google Icon
5/5/2022Fisher Asset Management LLC180,881$1.04M0.0%+37.6%0.177%Search for SEC Filing on Google Icon
5/5/2022New York State Common Retirement Fund807,503$4.62M0.0%+0.6%0.791%Search for SEC Filing on Google Icon
5/3/2022Cutter & CO Brokerage Inc.13,380$77K0.0%-18.0%0.013%Search for SEC Filing on Google Icon
5/3/2022Redmond Asset Management LLC69,759$0.40M0.1%+51.6%0.068%Search for SEC Filing on Google Icon
5/2/2022Congress Park Capital LLC127,748$0.73M0.4%+42.5%0.125%Search for SEC Filing on Google Icon
4/29/2022Nisa Investment Advisors LLC57,285$0.33M0.0%+5,179.7%0.056%Search for SEC Filing on Google Icon
4/26/2022Hennion & Walsh Asset Management Inc.283,954$1.62M0.1%-4.1%0.278%Search for SEC Filing on Google Icon
4/25/2022Zweig DiMenna Associates LLC51,500$0.30M0.0%N/A0.050%Search for SEC Filing on Google Icon
4/22/2022Oak Ridge Investments LLC146,436$0.84M0.1%-32.5%0.143%Search for SEC Filing on Google Icon
3/9/2022Norges Bank808,960$7.39M0.0%N/A0.792%Search for SEC Filing on Google Icon
3/3/2022Walleye Capital LLC48,905$0.45M0.0%N/A0.048%Search for SEC Filing on Google Icon
2/23/2022Barclays PLC141,864$1.30M0.0%+64.8%0.139%Search for SEC Filing on Google Icon
2/23/2022BlackRock Inc.7,682,201$70.14M0.0%+0.1%7.536%Search for SEC Filing on Google Icon
2/19/2022Wells Fargo & Company MN104,112$0.95M0.0%-38.4%0.102%Search for SEC Filing on Google Icon
2/19/2022Weiss Multi Strategy Advisers LLC42,500$0.39M0.0%+104.9%0.042%Search for SEC Filing on Google Icon
2/19/2022Woodline Partners LP557,799$5.09M0.1%N/A0.547%Search for SEC Filing on Google Icon
2/17/2022Goldman Sachs Group Inc.1,918,410$17.52M0.0%+19.8%1.882%Search for SEC Filing on Google Icon
2/17/2022Virtu Financial LLC18,306$0.17M0.0%N/A0.018%Search for SEC Filing on Google Icon
2/16/2022Allianz Asset Management GmbH215,644$1.97M0.0%N/A0.212%Search for SEC Filing on Google Icon
2/16/2022Zullo Investment Group Inc.3,300$30K0.0%N/A0.003%Search for SEC Filing on Google Icon
2/16/2022Deutsche Bank AG388,630$3.55M0.0%-26.6%0.381%Search for SEC Filing on Google Icon
2/16/2022California State Teachers Retirement System131,666$1.20M0.0%+2.0%0.129%Search for SEC Filing on Google Icon
2/16/2022Orchard Capital Managment LLC366,004$3.34M1.0%+2.0%0.359%Search for SEC Filing on Google Icon
2/16/2022Parametric Portfolio Associates LLC175,178$1.60M0.0%-1.5%0.172%Search for SEC Filing on Google Icon
2/15/2022Sei Investments Co.394,473$3.60M0.0%+21.0%0.387%Search for SEC Filing on Google Icon
2/15/2022Stifel Financial Corp52,038$0.48M0.0%-18.5%0.051%Search for SEC Filing on Google Icon
2/15/2022Susquehanna International Group LLP266,488$2.43M0.0%+27.5%0.261%Search for SEC Filing on Google Icon
2/15/2022Schonfeld Strategic Advisors LLC28,900$0.26M0.0%-42.9%0.028%Search for SEC Filing on Google Icon
2/15/2022Sofinnova Investments Inc.2,933,351$26.78M1.6%+27.5%2.878%Search for SEC Filing on Google Icon
2/15/2022Mackenzie Financial Corp54,135$0.49M0.0%+79.0%0.053%Search for SEC Filing on Google Icon
2/15/2022Millennium Management LLC1,004,798$9.17M0.0%N/A0.986%Search for SEC Filing on Google Icon
2/15/2022Cubist Systematic Strategies LLC117,431$1.07M0.0%+34.8%0.115%Search for SEC Filing on Google Icon
2/15/2022Crestline Management LP185,766$1.70M0.1%+80.6%0.182%Search for SEC Filing on Google Icon
2/14/2022Pier 88 Investment Partners LLC98,830$0.90M0.2%+110.6%0.097%Search for SEC Filing on Google Icon
2/14/2022D. E. Shaw & Co. Inc.1,350,491$12.33M0.0%-5.7%1.325%Search for SEC Filing on Google Icon
2/14/2022PDT Partners LLC63,370$0.58M0.0%N/A0.062%Search for SEC Filing on Google Icon
2/14/2022Squarepoint Ops LLC73,893$0.68M0.0%-70.6%0.072%Search for SEC Filing on Google Icon
2/14/2022Suvretta Capital Management LLC2,486,340$22.70M0.4%+66.8%2.439%Search for SEC Filing on Google Icon
2/14/2022CSS LLC IL30,000$0.27M0.0%-40.0%0.029%Search for SEC Filing on Google Icon
2/14/2022Alliancebernstein L.P.129,000$1.18M0.0%-9.9%0.127%Search for SEC Filing on Google Icon
2/14/2022Alpha Paradigm Partners LLC173,473$1.58M0.6%+173.1%0.170%Search for SEC Filing on Google Icon
2/14/2022Credit Suisse AG143,262$1.31M0.0%+32.1%0.141%Search for SEC Filing on Google Icon
2/14/2022State Street Corp7,692,411$70.23M0.0%+18.5%7.546%Search for SEC Filing on Google Icon
2/14/2022LPL Financial LLC16,250$0.15M0.0%+8.7%0.016%Search for SEC Filing on Google Icon
2/14/2022Goldman Sachs Group Inc.1,918,410$17.52M0.0%+19.8%1.882%Search for SEC Filing on Google Icon
2/14/2022Nuveen Asset Management LLC720,869$6.10M0.0%-3.7%0.707%Search for SEC Filing on Google Icon
2/14/2022Barclays PLC141,864$1.30M0.0%+64.8%0.139%Search for SEC Filing on Google Icon
2/14/2022GSA Capital Partners LLP34,374$0.31M0.0%-5.7%0.034%Search for SEC Filing on Google Icon
2/14/2022Invesco Ltd.62,562$0.57M0.0%-3.4%0.061%Search for SEC Filing on Google Icon
2/11/2022Geode Capital Management LLC1,711,608$15.63M0.0%+6.2%1.679%Search for SEC Filing on Google Icon
2/11/2022Ensign Peak Advisors Inc152,855$1.40M0.0%+24.2%0.150%Search for SEC Filing on Google Icon
2/11/2022Allianz Asset Management GmbH215,644$1.97M0.0%N/A0.212%Search for SEC Filing on Google Icon
2/11/2022Bank of Montreal Can162,130$1.51M0.0%-1.2%0.159%Search for SEC Filing on Google Icon
2/10/2022Candriam Luxembourg S.C.A.53,993$0.49M0.0%-67.7%0.053%Search for SEC Filing on Google Icon
2/10/2022Rhumbline Advisers103,098$0.94M0.0%-1.8%0.101%Search for SEC Filing on Google Icon
2/10/2022JPMorgan Chase & Co.6,254,766$57.11M0.0%+18.0%6.136%Search for SEC Filing on Google Icon
2/10/2022Cutter & CO Brokerage Inc.16,325$0.15M0.0%-47.1%0.016%Search for SEC Filing on Google Icon
2/10/2022Rafferty Asset Management LLC561,277$5.12M0.0%+109.8%0.551%Search for SEC Filing on Google Icon
2/10/2022Citigroup Inc.440,684$4.02M0.0%+124.5%0.432%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Heron Therapeutics logo
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy. The company is also developing ZYNRELEF, a dual-acting local anesthetic that delivers a fixed-dose combination of the local anesthetic bupivacaine and a low dose of the nonsteroidal anti-inflammatory drug meloxicam; HTX-019, an investigational agent for the prevention of postoperative nausea and vomiting; and HTX-034 for postoperative pain management, as well as is in Phase Ib/II clinical study in patients undergoing bunionectomy. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in San Diego, California.
Read More on Heron Therapeutics

Today's Range

Now: $3.61
Low: $3.47
High: $3.67

50 Day Range

MA: $5.19
Low: $3.30
High: $6.29

52 Week Range

Now: $3.61
Low: $3.12
High: $16.63

Volume

201,626 shs

Average Volume

2,306,845 shs

Market Capitalization

$369.95 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.37

Who are the company insiders with the largest holdings of Heron Therapeutics?

Heron Therapeutics' top insider shareholders include:
  1. Kimberly Manhard (EVP)
  2. Waage Christian (Director)
  3. Craig A Johnson (Director)
  4. David Leslie Szekeres (COO)
Learn More about top insider investors at Heron Therapeutics.

Who are the major institutional investors of Heron Therapeutics?

Heron Therapeutics' top institutional shareholders include:
  1. State Street Corp — 12.61%
  2. Vanguard Group Inc. — 9.69%
  3. BlackRock Inc. — 7.99%
  4. JPMorgan Chase & Co. — 6.00%
  5. Palisade Capital Management LLC NJ — 2.86%
  6. Suvretta Capital Management LLC — 2.80%
Learn More about top institutional investors of Heron Therapeutics stock.

Which institutional investors are selling Heron Therapeutics stock?

Within the last quarter, HRTX stock was sold by these institutional investors:
  1. Citigroup Inc.
  2. JPMorgan Chase & Co.
  3. Palisade Capital Management LLC NJ
  4. UBS Group AG
  5. Panagora Asset Management Inc.
  6. Oak Ridge Investments LLC
  7. Bank of Montreal Can
  8. Allianz Asset Management GmbH
In the last year, company insiders that have sold Heron Therapeutics company stock include:
  1. Kimberly Manhard (EVP)
  2. Waage Christian (Director)
Learn More investors selling Heron Therapeutics stock.

Which institutional investors are buying Heron Therapeutics stock?

Within the last quarter, HRTX stock was acquired by institutional investors including:
  1. State Street Corp
  2. Orchard Capital Managment LLC
  3. BlackRock Inc.
  4. Suvretta Capital Management LLC
  5. Vanguard Group Inc.
  6. Integral Health Asset Management LLC
  7. CM Management LLC
  8. Connor Clark & Lunn Investment Management Ltd.
The Safest Option in Trades!
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!